Submitted by Anonymous (not verified) on 4 November 2025 - 16:15
Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised